vs

Side-by-side financial comparison of Brookfield Asset Management Ltd. (BAM) and CABOT CORP (CBT). Click either name above to swap in a different company.

Brookfield Asset Management Ltd. is the larger business by last-quarter revenue ($1.1B vs $849.0M, roughly 1.3× CABOT CORP). Brookfield Asset Management Ltd. runs the higher net margin — 56.7% vs 8.6%, a 48.1% gap on every dollar of revenue.

Brookfield Asset Management Ltd. is a Canadian-American alternative asset manager. The company was founded in December 2022 as a spin-off of the asset management operations of Brookfield Corporation, and manages investments across real estate, infrastructure, renewable energy, private equity, and credit markets globally.

Cabot Corporation is an American specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company operates in over 20 countries with 36 manufacturing plants, eight research and development facilities, and 28 sales offices.

BAM vs CBT — Head-to-Head

Bigger by revenue
BAM
BAM
1.3× larger
BAM
$1.1B
$849.0M
CBT
Higher net margin
BAM
BAM
48.1% more per $
BAM
56.7%
8.6%
CBT

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
BAM
BAM
CBT
CBT
Revenue
$1.1B
$849.0M
Net Profit
$615.0M
$73.0M
Gross Margin
24.9%
Operating Margin
84.2%
15.2%
Net Margin
56.7%
8.6%
Revenue YoY
-11.1%
Net Profit YoY
-21.5%
EPS (diluted)
$1.37

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BAM
BAM
CBT
CBT
Q4 25
$1.1B
$849.0M
Q3 25
$974.0M
$899.0M
Q2 25
$931.0M
$923.0M
Q1 25
$954.0M
$936.0M
Q4 24
$955.0M
Q3 24
$873.0M
$1.0B
Q2 24
$821.0M
$1.0B
Q1 24
$786.0M
$1.0B
Net Profit
BAM
BAM
CBT
CBT
Q4 25
$615.0M
$73.0M
Q3 25
$692.0M
$43.0M
Q2 25
$584.0M
$101.0M
Q1 25
$507.0M
$94.0M
Q4 24
$93.0M
Q3 24
$537.0M
$137.0M
Q2 24
$124.0M
$109.0M
Q1 24
$373.0M
$84.0M
Gross Margin
BAM
BAM
CBT
CBT
Q4 25
24.9%
Q3 25
24.5%
Q2 25
26.4%
Q1 25
25.7%
Q4 24
24.6%
Q3 24
24.0%
Q2 24
25.2%
Q1 24
24.1%
Operating Margin
BAM
BAM
CBT
CBT
Q4 25
84.2%
15.2%
Q3 25
79.1%
15.2%
Q2 25
70.8%
18.1%
Q1 25
61.0%
17.3%
Q4 24
16.2%
Q3 24
72.5%
15.0%
Q2 24
80.4%
16.9%
Q1 24
56.5%
15.3%
Net Margin
BAM
BAM
CBT
CBT
Q4 25
56.7%
8.6%
Q3 25
71.0%
4.8%
Q2 25
62.7%
10.9%
Q1 25
53.1%
10.0%
Q4 24
9.7%
Q3 24
61.5%
13.7%
Q2 24
15.1%
10.7%
Q1 24
47.5%
8.2%
EPS (diluted)
BAM
BAM
CBT
CBT
Q4 25
$1.37
Q3 25
$0.80
Q2 25
$1.86
Q1 25
$1.69
Q4 24
$1.67
Q3 24
$2.41
Q2 24
$1.94
Q1 24
$1.49

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BAM
BAM
CBT
CBT
Cash + ST InvestmentsLiquidity on hand
$1.6B
$230.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$8.9B
$1.6B
Total Assets
$17.0B
$3.8B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BAM
BAM
CBT
CBT
Q4 25
$1.6B
$230.0M
Q3 25
$1.1B
$258.0M
Q2 25
$480.0M
$239.0M
Q1 25
$332.0M
$213.0M
Q4 24
$183.0M
Q3 24
$223.0M
Q2 24
$10.0M
$197.0M
Q1 24
$206.0M
Total Debt
BAM
BAM
CBT
CBT
Q4 25
Q3 25
$1.1B
Q2 25
Q1 25
Q4 24
Q3 24
$1.1B
Q2 24
Q1 24
Stockholders' Equity
BAM
BAM
CBT
CBT
Q4 25
$8.9B
$1.6B
Q3 25
$8.5B
$1.6B
Q2 25
$8.5B
$1.5B
Q1 25
$8.5B
$1.4B
Q4 24
$1.4B
Q3 24
$9.0B
$1.4B
Q2 24
$3.2B
$1.3B
Q1 24
$2.2B
$1.4B
Total Assets
BAM
BAM
CBT
CBT
Q4 25
$17.0B
$3.8B
Q3 25
$16.5B
$3.8B
Q2 25
$16.1B
$3.8B
Q1 25
$15.0B
$3.8B
Q4 24
$3.6B
Q3 24
$3.7B
Q2 24
$4.2B
$3.6B
Q1 24
$3.6B
Debt / Equity
BAM
BAM
CBT
CBT
Q4 25
Q3 25
0.70×
Q2 25
Q1 25
Q4 24
Q3 24
0.75×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BAM
BAM
CBT
CBT
Operating Cash FlowLast quarter
$562.0M
$126.0M
Free Cash FlowOCF − Capex
$57.0M
FCF MarginFCF / Revenue
6.7%
Capex IntensityCapex / Revenue
8.1%
Cash ConversionOCF / Net Profit
0.91×
1.73×
TTM Free Cash FlowTrailing 4 quarters
$401.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BAM
BAM
CBT
CBT
Q4 25
$562.0M
$126.0M
Q3 25
$745.0M
$219.0M
Q2 25
$529.0M
$249.0M
Q1 25
$265.0M
$73.0M
Q4 24
$124.0M
Q3 24
$567.0M
$204.0M
Q2 24
$159.0M
$207.0M
Q1 24
$516.0M
$176.0M
Free Cash Flow
BAM
BAM
CBT
CBT
Q4 25
$57.0M
Q3 25
$155.0M
Q2 25
$188.0M
Q1 25
$1.0M
Q4 24
$47.0M
Q3 24
$112.0M
Q2 24
$155.0M
Q1 24
$133.0M
FCF Margin
BAM
BAM
CBT
CBT
Q4 25
6.7%
Q3 25
17.2%
Q2 25
20.4%
Q1 25
0.1%
Q4 24
4.9%
Q3 24
11.2%
Q2 24
15.3%
Q1 24
13.1%
Capex Intensity
BAM
BAM
CBT
CBT
Q4 25
8.1%
Q3 25
7.1%
Q2 25
6.6%
Q1 25
7.7%
Q4 24
8.1%
Q3 24
9.2%
Q2 24
5.1%
Q1 24
4.2%
Cash Conversion
BAM
BAM
CBT
CBT
Q4 25
0.91×
1.73×
Q3 25
1.08×
5.09×
Q2 25
0.91×
2.47×
Q1 25
0.52×
0.78×
Q4 24
1.33×
Q3 24
1.06×
1.49×
Q2 24
1.28×
1.90×
Q1 24
1.38×
2.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BAM
BAM

Incentive Fees$452.0M42%
Infrastruture$332.0M31%
Private Equity$174.0M16%
Renewable Power And Transition$66.0M6%
Other$47.0M4%
Management And Advisory Fees$14.0M1%

CBT
CBT

Reinforcement Materials$520.0M61%
Performance Chemicals$300.0M35%
Shipping And Handling$25.0M3%
Other Products And Services$4.0M0%

Related Comparisons